Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA35 Injection for Gingivitis and Periodontitis
NCT05812300Completed
- Sponsor
- Dove Medical Press
- Start
- Jun 2023
- Primary completion
- Jan 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of ha35 in gingivitis and periodontitis, sponsored by Dove Medical Press. Primary endpoints: Measurement of gum discomfort at 7 days, Measurement of gum redness and swelling at 7 days and 1 more. Started Jun 2023; status: completed.
02
Drugs
ha35
03
Conditions
gingivitisperiodontitis
Beyond the preview
Go deeper on NCT05812300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05812300.